Sun Pharma Advanced Research Company Ltd Gains 6.36%: Key Technical Shifts and Market Moves
2026-11-14 16:00:04Key Events This Week Nov 09: Intraday high surge to Rs.215.10 (+8.43%) Nov 11: Marginal price increase with steady volume Nov 12: Technical momentum shifts to bullish amid mixed signals Nov 13: Price correction to Rs.205.80 (-3.27%) closes the week Week OpenRs.193.50 Week CloseRs.205.80<d...
Read More
Sun Pharma Advanced Research Company Ltd is Rated Hold
2026-11-09 10:10:04Sun Pharma Advanced Research Company Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Sun Pharma Advanced Research Company Ltd Surges 8.43% to Day's High of Rs 215.1 — Outperforms Sector by 6.92 Percentage Points
2026-11-09 09:56:26The Sensex declined 0.24% on 09 Nov 2026, while Sun Pharma Advanced Research Company Ltd surged 8.43%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 7 percentage points. This sharp single-session gain rewrites the short-term narrative for the stock, which has been on a positive trajectory over the past week.
Read MoreSun Pharma Advanced Research Company Gains 9.38%: 3 Key Factors Driving the Week
2026-11-07 16:01:46Key Events This Week 2 Nov: Stock opens at Rs.175.10, down 1.02% amid broader market gains 3 Nov: Reports flat quarterly performance and valuation shift; stock closes Rs.176.00 (+0.51%) 5 Nov: Intraday high of Rs.199.95 with a 7.23% surge; closes Rs.196.20 (+5.88%) 6 Nov: Slight correction to Rs.193.50 (-1.38%) as week closes Week OpenRs.176.90 <d...
Read More
Sun Pharma Advanced Research Company Ltd Surges 7.23% to Day's High of Rs 199.95 — Outperforms Sector by 6.49 Percentage Points
2026-11-05 14:46:54The Sensex climbed 2.72% on 05 Nov 2026, yet Sun Pharma Advanced Research Company Ltd outpaced the broader market with a 7.23% gain, touching an intraday high of Rs 199.95. This 6.49-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read More
Sun Pharma Advanced Research Company Ltd Reports Flat Quarterly Performance Amid Mixed Financial Trends
2026-11-03 13:00:13Sun Pharma Advanced Research Company Ltd (SPARC) has reported a marked shift in its financial trend, moving from positive growth to a flat performance in the quarter ended September 2026. Despite robust year-to-date profit figures, the latest quarter reveals significant contraction in revenue and profitability metrics, signalling challenges ahead for this small-cap pharmaceutical player.
Read More
Sun Pharma Advanced Research Company Ltd is Rated Hold
2026-10-29 10:11:30Sun Pharma Advanced Research Company Ltd is rated 'Hold' by MarketsMOJO. This rating was last updated on 10 August 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 29 October 2026, providing investors with the latest perspective on the company’s performance and valuation.
Read More
Sun Pharma Advanced Research Company Ltd: Valuation Shifts Signal Changing Market Sentiment
2026-10-23 08:01:42Sun Pharma Advanced Research Company Ltd (SPARC) has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging sector backdrop and a mixed performance relative to peers. Investors are now reassessing the stock’s price attractiveness, with key metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling a more balanced risk-reward profile.
Read More
Sun Pharma Advanced Research Company Ltd is Rated Hold
2026-10-18 10:10:17Sun Pharma Advanced Research Company Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 October 2026, providing investors with an up-to-date perspective on its performance and outlook.
Read MoreReceipt Of No-Objection Letters From The Stock Exchanges For Reclassification Of Promoter Group
12-Nov-2026 | Source : BSEReceipt of No- Objection Letters from the Stock Exchanges for Reclassification of Promoter Group
Clarification Regarding Increase In Volume
11-Nov-2026 | Source : BSEResponse of Clarification sought from BSE Limited
Clarification sought from Sun Pharma Advanced Research Company Ltd
11-Nov-2026 | Source : BSEThe Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on November 11 2026 with reference to Movement in Volume.
The reply is awaited.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Sun Pharma Advanced Research Company Ltd has announced 5:116 rights issue, ex-date: 16 Mar 16